CS265248B2 - Process for preparing analogs of rebeccamycine - Google Patents

Process for preparing analogs of rebeccamycine Download PDF

Info

Publication number
CS265248B2
CS265248B2 CS878249A CS824987A CS265248B2 CS 265248 B2 CS265248 B2 CS 265248B2 CS 878249 A CS878249 A CS 878249A CS 824987 A CS824987 A CS 824987A CS 265248 B2 CS265248 B2 CS 265248B2
Authority
CS
Czechoslovakia
Prior art keywords
rebeccamycin
formula
derivative
hydrogen atom
radical
Prior art date
Application number
CS878249A
Other languages
Czech (cs)
English (en)
Other versions
CS824987A2 (en
Inventor
Takushi Kaneko
Henry S Wong
Jacob J Utzig
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CS824987A2 publication Critical patent/CS824987A2/cs
Publication of CS265248B2 publication Critical patent/CS265248B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
CS878249A 1986-11-21 1987-11-17 Process for preparing analogs of rebeccamycine CS265248B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/933,428 US4785085A (en) 1986-11-21 1986-11-21 Rebeccamycin analogs

Publications (2)

Publication Number Publication Date
CS824987A2 CS824987A2 (en) 1989-01-12
CS265248B2 true CS265248B2 (en) 1989-10-13

Family

ID=25463937

Family Applications (1)

Application Number Title Priority Date Filing Date
CS878249A CS265248B2 (en) 1986-11-21 1987-11-17 Process for preparing analogs of rebeccamycine

Country Status (28)

Country Link
US (1) US4785085A (da)
EP (1) EP0269025B1 (da)
JP (1) JPS63198695A (da)
KR (1) KR910000897B1 (da)
CN (1) CN1019806B (da)
AT (1) ATE84539T1 (da)
AU (1) AU614068B2 (da)
CA (1) CA1287349C (da)
CS (1) CS265248B2 (da)
CY (1) CY1701A (da)
DE (1) DE3783577T2 (da)
DK (1) DK165986C (da)
EG (1) EG18409A (da)
ES (1) ES2053510T3 (da)
FI (1) FI86189C (da)
GR (1) GR3006776T3 (da)
HK (1) HK49093A (da)
HU (1) HU201773B (da)
IE (1) IE60595B1 (da)
IL (1) IL84515A (da)
MX (1) MX9202849A (da)
MY (1) MY102722A (da)
NO (1) NO167741C (da)
NZ (1) NZ222544A (da)
PT (1) PT86188B (da)
SG (1) SG25193G (da)
YU (1) YU46087B (da)
ZA (1) ZA878714B (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
US5496809A (en) * 1989-05-10 1996-03-05 Bristol-Myers Squibb Co Stable solutions of rebeccamycin analog
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
EP0445736A1 (en) * 1990-03-06 1991-09-11 Bristol-Myers Squibb Company Rebeccamycin analog and pharmaceutical composition containing it
DE69127691T2 (de) * 1990-05-11 1998-01-15 Banyu Pharmaceutical Co., Ltd., Tokio/Tokyo Be-13793c-derivat mit antitumorwirkung
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
US5437996A (en) * 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
ATE175873T1 (de) * 1992-03-20 1999-02-15 Wellcome Found Weitere indolderivate mit antiviraler wirkung
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
NO308798B1 (no) * 1993-12-07 2000-10-30 Lilly Co Eli Proteinkinase-C-hemmere, anvendelse av samme for fremstilling av farmasøytika samt farmasøytisk formulering omfattende samme
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
DE69418978T2 (de) * 1993-12-07 1999-10-28 Eli Lilly And Co., Indianapolis Synthese von Bisindolylmaleimiden
AU1339895A (en) * 1993-12-23 1995-07-10 Eli Lilly And Company Protein kinase c inhibitors
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5804564A (en) * 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
WO1995030682A1 (en) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
WO1995034663A1 (en) * 1994-06-13 1995-12-21 Banyu Pharmaceutical Co., Ltd. Gene coding for glycosyltransferase and use thereof
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
EP0695755B1 (en) * 1994-08-04 1998-10-21 F. Hoffmann-La Roche AG Pyrrolocarbazole
AU6836696A (en) * 1995-09-05 1997-03-27 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
JP3258334B2 (ja) * 1996-03-20 2002-02-18 イーライ・リリー・アンド・カンパニー インドリルマレイミドの合成
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
MXPA03008589A (es) 2001-03-22 2003-12-08 Bristol Myers Squibb Co Derivados de azucar citotoxicos selectivos de topoisomerasa i de indolopirrolocarbazoles.
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
WO2005026185A1 (ja) * 2003-09-16 2005-03-24 Banyu Pharmaceutical Co., Ltd. 抗腫瘍性新規インドロピロロカルバゾール誘導体
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
BRPI1011188B1 (pt) 2009-05-06 2019-10-15 Laboratory Skin Care, Inc. Composições de liberação dérmica compreendendo complexos de partículas de agente ativo-fosfato de cálcio e métodos para usar as mesmas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102898489B (zh) * 2010-11-24 2014-04-02 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法
CN102125578B (zh) * 2010-11-24 2013-03-27 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4552842A (en) * 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１

Also Published As

Publication number Publication date
EP0269025A3 (en) 1990-08-29
CN87107928A (zh) 1988-08-10
JPH05400B2 (da) 1993-01-05
IE873152L (en) 1988-05-21
FI875091A7 (fi) 1988-05-22
NZ222544A (en) 1990-11-27
NO167741C (no) 1991-12-04
PT86188A (en) 1987-12-01
HUT45543A (en) 1988-07-28
EP0269025B1 (en) 1993-01-13
KR880006246A (ko) 1988-07-22
IE60595B1 (en) 1994-07-27
HK49093A (en) 1993-05-27
ES2053510T3 (es) 1994-08-01
FI875091A0 (fi) 1987-11-18
US4785085A (en) 1988-11-15
GR3006776T3 (da) 1993-06-30
FI86189C (fi) 1992-07-27
YU208687A (en) 1988-10-31
NO167741B (no) 1991-08-26
DK165986B (da) 1993-02-22
IL84515A0 (en) 1988-04-29
ATE84539T1 (de) 1993-01-15
AU8114887A (en) 1988-05-26
HU201773B (en) 1990-12-28
CN1019806B (zh) 1992-12-30
SG25193G (en) 1993-05-21
DK612987A (da) 1988-05-22
DE3783577D1 (de) 1993-02-25
DE3783577T2 (de) 1993-05-19
DK165986C (da) 1993-07-19
YU46087B (sh) 1992-12-21
PT86188B (pt) 1990-11-07
NO874857L (no) 1988-05-24
EG18409A (en) 1993-02-28
KR910000897B1 (ko) 1991-02-12
CY1701A (en) 1994-01-14
NO874857D0 (no) 1987-11-20
EP0269025A2 (en) 1988-06-01
FI86189B (fi) 1992-04-15
MX9202849A (es) 1992-06-30
CA1287349C (en) 1991-08-06
JPS63198695A (ja) 1988-08-17
DK612987D0 (da) 1987-11-20
ZA878714B (da) 1988-05-20
CS824987A2 (en) 1989-01-12
AU614068B2 (en) 1991-08-22
IL84515A (en) 1991-11-21
MY102722A (en) 1992-09-30

Similar Documents

Publication Publication Date Title
CS265248B2 (en) Process for preparing analogs of rebeccamycine
US5070092A (en) Pyrroloindole derivatives related to dc-88a compound
US5187186A (en) Pyrroloindole derivatives
US4808613A (en) Rebeccamycin derivative containing pharmaceutical composition
US5977165A (en) Radicicol derivatives
JPH01308267A (ja) 新規なアリステロマイシン／アデノシン誘導体類
US5922860A (en) Antitumor indolopyrrolocarbazole derivatives
EP1409486A1 (fr) Derives de pyrido-pyrido-pyrrolo pyrrolo-indole et pyrido-pyrrolo pyrrolo carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2801054A1 (fr) Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HU217551B (hu) 6[(2-Hidroxi-etil)-amino-alkil]-5,11-dioxo-5,6-dihidro-11H-indén[1,2-c]izokinolin-származékok, valamint eljárás előállításukra, továbbá hatóanyagként e vegyületeket tartalmazó gyógyászati készítmények
FR2845996A1 (fr) Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0760375B1 (en) Antitumor indolopyprolocarbazole derivative
EP0378706B1 (en) 5-substituted uridine derivatives and intermediates for their preparation
US4576945A (en) Hexaalkylmelamine-amino-oxy compounds
US5100881A (en) N-(23-vincristinoyl) and n-(5'-noranhydro-23-vinblastinoyl) compounds of 1-aminomethylphosphonic acid useful for the treatment of neoplastic diseases
EP0456514B1 (en) 2-Fluoroneplanocin A and its production
EP0601520A1 (en) Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same
JPH0834788A (ja) ピロロベンゾカルバゾール誘導体及びその製造方法
GB2287463A (en) Bis-anthracycline derivatives
HU188152B (en) Process for the preparation of anticancer n-phthalidyl-5-fluoro-uracile derivatives
HK1000707A (en) Dc-88a derivatives
JPH092951A (ja) 抗腫瘍剤及びニドルフィン誘導体
JPWO1994006799A1 (ja) 血小板減少症治療剤

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20061117